Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BCAS4
REST API REST API
Homo sapiens
BCAS4 is differentially expressed in 217 experiments: 71 organism parts: mammary gland, tonsil, ... (69 more);, 168 disease states: normal, healthy, ... (166 more);, 82 cell types 322 cell lines 23 compound treatments and 70 other conditions.
Synonyms FLJ20495, CNOL
Orthologs ENSCING00000011938 (Ciona intestinalis)   Q0IIA9_BOVIN (Bos taurus)   BCAS4 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytoplasm
UniProt Accession Q8TDM0, F8WE92
Search EB-eye ENSG00000124243
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-GEOD-1577, E-TABM-145, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (32 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
PC3
2
E-GEOD-14464, E-MEXP-2034
DU145
2
E-GEOD-17482, E-GEOD-20089
MCF-7
2
E-GEOD-20081, E-GEOD-3529
MOLT4
2
E-MTAB-62, E-MTAB-37
T84
2
E-GEOD-1474, E-MTAB-37
316 more value(s).


Cell type

studied in E-GEOD-22529, E-TABM-40, E-GEOD-20193, E-GEOD-19397, E-GEOD-3920, ... (43 experiments)

Factor Value U/D Experiments
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
fibroblast
2
E-GEOD-3920, E-GEOD-3204
endothelial cell
1
2
E-GEOD-19240, E-GEOD-3920, E-GEOD-3998
liver cancer
1
E-GEOD-21154
LCC
1
E-GEOD-19188
76 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-TABM-15, E-GEOD-16363, ... (50 experiments)

Factor Value U/D Experiments
Ewing sarcoma
2
E-GEOD-1825, E-MTAB-37
breast carcinoma
2
E-TABM-276, E-GEOD-7307
colon carcinoma
2
E-MTAB-37, E-MTAB-62
Raji Burkitt's lymphoma
2
E-AFMX-5, E-TABM-145
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
lymphoma
2
E-MTAB-62, E-MTAB-37
162 more value(s).


Compound treatment

studied in E-GEOD-7400, E-TABM-782, E-GEOD-5824, E-GEOD-6462, E-MEXP-1958, ... (13 experiments)

Factor Value U/D Experiments
none
6
E-GEOD-5824, E-MEXP-1958, E-MEXP-1601, E-GEOD-7307, E-GEOD-7400, ... (6 experiments)
unknown
1
E-GEOD-7307
dimethyl sulfoxide
1
E-GEOD-5824
actinomycin D
2
1
E-GEOD-6400
TTA
1
1
E-MEXP-2590
granulocyte-colony stimulating factor
1
E-GEOD-7400
17 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-22513, E-GEOD-19246, E-GEOD-4619, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

crosslinker and crosslinking wavelength
studied in E-GEOD-21918

Developmental stage
studied in E-GEOD-19743, E-MEXP-2359, E-GEOD-6236, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-2509

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-4025, E-MEXP-1482, E-GEOD-20847

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-TABM-601, E-MEXP-1838 ... (5 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-MEXP-2657, E-MEXP-2146, E-GEOD-20505 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-GEOD-3720, E-MEXP-2069, ... (23 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-12662

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-26495, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636

Population
studied in E-GEOD-4342

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246, E-GEOD-1343

RNAi
studied in E-MEXP-2115, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-GEOD-19246, E-GEOD-13818

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-1561

Vehicle
studied in E-GEOD-5258

Processing time: 0.314 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM